Oncology Institute (TOIIW) Tax Provisions (2020 - 2025)

Oncology Institute has reported Tax Provisions for 5 years, with the latest figure at -$131000.0 in Q2 2025.

• For the quarter ending Q2 2025, Tax Provisions changed N/A year-over-year to -$131000.0; the trailing twelve-month figure through Mar 2026 stood at -$131000.0 (changed N/A YoY), and the FY2025 full-year result was -$131000.0, changed N/A from the prior year.
• Tax Provisions for Q2 2025 stood at -$131000.0, up from -$314000.0 in the prior quarter.
• The five-year high for Tax Provisions was $799000.0 in Q3 2021, with the low at -$2.5 million in Q4 2021.
• Historically, Tax Provisions has averaged -$83153.8 across 4 years, with a median of $44000.0 in 2023.
• The largest YoY upside for Tax Provisions was 6254.89% in 2021 against a maximum downside of 388.16% in 2021.
• Oncology Institute's Tax Provisions stood at -$2.5 million in 2021, then jumped by 85.13% to -$367000.0 in 2022, then increased by 14.44% to -$314000.0 in 2023, then surged by 58.28% to -$131000.0 in 2025.
• The last three Tax Provisions figures came in at -$131000.0 (Q2 2025), -$314000.0 (Q4 2023), and $135000.0 (Q3 2023), per Business Quant data.